Albert David

70
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
761.05
7.45 (0.99%)
BSENSE

Nov 20

BSE+NSE Vol: 4.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -3.52% vs -4.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 81.42% vs -93.27% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 430.80% vs 26.70% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -108.69% vs -77.19% in Mar 2025

Compare Profit and Loss Results of Albert David
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
333.00
147.00
186.00
126.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
333.00
147.00
186.00
126.53%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
-4.00
8.00
200.00%
Raw Materials Consumed
108.00
102.00
6.00
5.88%
Power & Fuel Cost
15.00
1.00
14.00
1,400.00%
Employee Cost
102.00
7.00
95.00
1,357.14%
Operating Expenses
8.00
5.00
3.00
60.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
32.00
2.00
30.00
1,500.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
23.00
0.00
23.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
327.00
134.00
193.00
144.03%
Operating Profit (PBDIT) excl Other Income
5.00
13.00
-8.00
-61.54%
Other Income
7.00
0.00
7.00
0%
Operating Profit (PBDIT)
13.00
13.00
0.00
0.00%
Interest
2.00
3.00
-1.00
-33.33%
Profit before Depriciation and Tax
10.00
10.00
0.00
0.00%
Depreciation
9.00
4.00
5.00
125.00%
Profit Before Taxation & Exceptional Items
0.00
5.00
-5.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
5.00
-5.00
-100.00%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
-1.00
4.00
-5.00
-125.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
249.00
9.00
240.00
2,666.67%
Profit Available for appropriations
247.00
14.00
233.00
1,664.29%
Appropriations
247.00
14.00
233.00
1,664.29%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
-2.62
4.49
-7.11
-158.35%
Profit And Loss - Net Sales
Net Sales 333.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.52% vs -4.61% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 81.42% vs -93.27% in Mar 2025

Profit And Loss - Interest
Interest 2.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 430.80% vs 26.70% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax -1.49 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -108.69% vs -77.19% in Mar 2025